These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17638915)

  • 1. Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells.
    Jacob JB; Kong YC; Meroueh C; Snower DP; David CS; Ho YS; Wei WZ
    Cancer Res; 2007 Jul; 67(14):7020-7. PubMed ID: 17638915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of DNA vaccines encoding self or heterologous Her-2/neu in Her-2 or neu transgenic mice.
    Jacob J; Radkevich O; Forni G; Zielinski J; Shim D; Jones RF; Wei WZ
    Cell Immunol; 2006 Apr; 240(2):96-106. PubMed ID: 16930573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential requirement for autoantibody-producing B cells for induction of lymphocytic versus granulomatous experimental autoimmune thyroiditis.
    Braley-Mullen H; Sharp GC; Kyriakos M
    J Immunol; 1994 Jan; 152(1):307-14. PubMed ID: 8254200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrent induction of antitumor immunity and autoimmune thyroiditis in CD4+ CD25+ regulatory T cell-depleted mice.
    Wei WZ; Jacob JB; Zielinski JF; Flynn JC; Shim KD; Alsharabi G; Giraldo AA; Kong YC
    Cancer Res; 2005 Sep; 65(18):8471-8. PubMed ID: 16166327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+CD25+ naturally occurring regulatory T cells and not lymphopenia play a role in the pathogenesis of iodide-induced autoimmune thyroiditis in NOD-H2h4 mice.
    Nagayama Y; Horie I; Saitoh O; Nakahara M; Abiru N
    J Autoimmun; 2007; 29(2-3):195-202. PubMed ID: 17826032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference with CD4+CD25+ T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody.
    Morris GP; Kong YC
    J Autoimmun; 2006 Feb; 26(1):24-31. PubMed ID: 16253477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity.
    Whittington PJ; Radkevich-Brown O; Jacob JB; Jones RF; Weise AM; Wei WZ
    Cancer Immunol Immunother; 2009 May; 58(5):759-67. PubMed ID: 18836716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice.
    Flynn JC; Fuller BE; Giraldo AA; Panos JC; David CS; Kong YC
    J Autoimmun; 2001 Aug; 17(1):7-15. PubMed ID: 11488633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of HLA class II transgenic mice to study autoimmune regulation.
    Kong YC; Flynn JC; Banga JP; David CS
    Thyroid; 2007 Oct; 17(10):995-1003. PubMed ID: 17900224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer.
    Yamamoto M; Kamigaki T; Yamashita K; Hori Y; Hasegawa H; Kuroda D; Moriyama H; Nagata M; Ku Y; Kuroda Y
    Oncol Rep; 2009 Aug; 22(2):337-43. PubMed ID: 19578774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinctive modulation by IL-4 and IL-10 of the effector function of murine thyroglobulin-primed cells in "transfer-experimental autoimmune thyroiditis".
    Mignon-Godefroy K; Brazillet MP; Rott O; Charreire J
    Cell Immunol; 1995 May; 162(2):171-7. PubMed ID: 7743543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental autoimmune thyroiditis in nonobese diabetic mice lacking interferon regulatory factor-1.
    Jin Z; Mori K; Fujimori K; Hoshikawa S; Tani J; Satoh J; Ito S; Satomi S; Yoshida K
    Clin Immunol; 2004 Nov; 113(2):187-92. PubMed ID: 15451476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumvention of the induction of resistance in murine experimental autoimmune thyroiditis by recombinant IL-1 beta.
    Nabozny GH; Kong YC
    J Immunol; 1992 Aug; 149(3):1086-92. PubMed ID: 1634763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A thyroxine-containing thyroglobulin peptide induces both lymphocytic and granulomatous forms of experimental autoimmune thyroiditis.
    Braley-Mullen H; Sharp GC
    J Autoimmun; 1997 Dec; 10(6):531-40. PubMed ID: 9451592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the induction and resolution of granulomatous experimental autoimmune thyroiditis in mice by CD8+ T cells.
    Braley-Mullen H; McMurray RW; Sharp GC; Kyriakos M
    Cell Immunol; 1994 Feb; 153(2):492-504. PubMed ID: 8118878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.
    Kari S; Flynn JC; Zulfiqar M; Snower DP; Elliott BE; Kong YC
    Thyroid; 2013 Dec; 23(12):1590-9. PubMed ID: 23777580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.
    Kong YC; Jacob JB; Flynn JC; Elliott BE; Wei WZ
    Autoimmun Rev; 2009 Sep; 9(1):28-33. PubMed ID: 19254781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.
    Jacob JB; Kong YC; Nalbantoglu I; Snower DP; Wei WZ
    J Immunol; 2009 May; 182(9):5873-81. PubMed ID: 19380836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
    Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
    Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.